However, our preliminary data showed that no significant variations were observed in the culture media of MM primary cell lines at baseline and after uPAR inhibitor treatments, suggesting that HGF-related pathways are not activated outside the BM niche without extracellular matrix interaction. The gene discussed is HGF; the disease is Miyoshi myopathy.